Global Drug Device Combination Products Market 2015-2019

Market outlook of the global drug device combination products market

Drug device combination products consist of two regulated components, an active pharmaceutical ingredient and a medical device, which are chemically of physically combined to develop a single component. The global drug device combination products market is expected to exhibit rapid growth during the forecast period and is positively affected by factors like its high revenue generating capacity across the healthcare sector and its ability to optimize product life cycles. These factors augment the prospects for growth in this market during the forecast period and results in its impressive CAGR of more than 11% by 2019.

The increase in patient population for chronic diseases is the key driver for the growth of this market. The prevalence of chronic diseases like cardiovascular disease, diabetes, and respiratory diseases is estimated to increase rapidly during the forecast period. This increase in the prevalence of chronic diseases is estimated to bolster the demand for smooth and efficient drug delivery devices, which in turn would augment the prospects for growth in this market during the forecast period.

Product-based segmentation of the drug device combination products market

• Drug-eluting stents
• Prefilled syringes
• Wearable injectors
• Insulin injector drug